Merck Global Health Innovation Fund

Portfolio

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary sector focus of Merck Global Health Innovation Fund's investments?

Merck Global Health Innovation Fund primarily invests in the Health Tech & Life Sciences sector, with all its portfolio companies and investment rounds concentrated in this area.

Can you name some notable companies in Merck Global Health Innovation Fund's portfolio?

Notable companies in Merck Global Health Innovation Fund's portfolio include VBL Therapeutics and medCPU. For a complete list, please refer to startupim.

What is the range of investment amounts made by Merck Global Health Innovation Fund?

Merck Global Health Innovation Fund's investments range from $1.3 million to $40 million per round.

Has Merck Global Health Innovation Fund had any exits from its portfolio companies?

Yes, Merck Global Health Innovation Fund had an exit in October 2014 when VBL Therapeutics went public on NASDAQ with a valuation of $120 million, having raised $40 million in capital.

When did Merck Global Health Innovation Fund make its first investment?

Merck Global Health Innovation Fund made its first investment in October 2010.

What is the most recent investment date for Merck Global Health Innovation Fund?

Merck Global Health Innovation Fund's most recent investment recorded was in February 2016, in medCPU for $35 million.

Does Merck Global Health Innovation Fund typically act as a lead investor?

According to startupim data, Merck Global Health Innovation Fund has a lead investor share of 0, indicating it does not typically act as a lead investor in its recorded rounds.

What funding stages does Merck Global Health Innovation Fund participate in?

Merck Global Health Innovation Fund has participated in B Round and Convertible Debt stages, as well as undisclosed funding stages.